-
摘要:
目的 观察低分化甲状腺癌(poorly differentiated thyroid carcinoma, PDTC)的临床病理特点。 方法 回顾性分析北京协和医院12例符合都灵诊断共识的PDTC临床、影像和病理学资料, 并采用EnVision法进行免疫组织化学标记。 结果 12例PDTC病例中11例为女性, 1例为男性, 平均发病年龄53.6岁。临床均表现为前颈部肿块, B超示肿物为低回声实性结节。5例患者肿瘤主要呈粱状生长, 4例主要呈岛状生长, 3例主要呈实性生长。免疫组化, 11例阳性表达TTF1;10例阳性表达甲状腺球蛋白; 4例P53弥漫阳性表达, 3例局灶阳性表达; Ki67增殖指数3%~25%不等。随访期间, 2例患者分别于术后4年及术后7.5年死于肿瘤播散。 结论 PDTC是一种独特的且较少见的甲状腺恶性肿瘤, 其临床病理特点介于高分化甲状腺癌与未分化甲状腺癌之间。 Abstract:Objective To investigate the clinicopathological characteristics of poorly differentiated thyroid carcinoma (PDTC). Methods The clinical and pathological features as well as the imaging findings of 12 cases of PDTC were retrospectively reviewed. Results The 12 patients, 1 man and 11 women, with an average age of 53.6 years, presented with painless mass at the anterior neck. Grossly, the tumor had a nodular appearance. Histologically, the predominantly insular pattern was found in 4 tumors, the trabecular architecture in 5 tumors, and the solid flake architecture in 3 tumors. Immunohistochemically, TTF1 was positive in 11 cases. Thyroglobulin expression was noted in 10 cases. P53 immunostaining showed diffuse positivity in 4 cases and focal positivity in 3 cases. The Ki67 proliferative index ranged from 3% to 25%. Two patients died of the tumor progression 4 and 7.5 years after the surgery, respectively. Conclusion PDTC is a rare disease with clinicopathological characteristics intermediate between follicular/papillary and anaplastic carcinomas. -
Key words:
- thyroid /
- poorly differentiated carcinoma /
- insular carcinoma
-
表 1 12例低分化甲状腺癌患者临床病理特点
-
[1] Sobrinho-Simoes M, Sambade C, Fonseca E, et al. Poorly differentiated carcinomas of the thyroid gland:a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors[J]. Int J Surg Pathol, 2002, 10:123-131. doi: 10.1177/106689690201000205 [2] Cabanne F, Gerard-Marchant R, Heimann R, et al. Malignant tumors of the thyroidgland. Problems of histopathologic diagnosis. Apropos of 692 lesions collected by the thyroid cancer Cooperative Group of the O. E. R. T. C[J]. Ann Anat Pathol (Paris), 1974, 19:129-148. http://europepmc.org/abstract/MED/4480015 [3] Pilotti S, Collini P, Mariani L, et al. Insular carcinoma:a distinct de novo entity among follicular carcinomas of the thyroid gland[J]. Am J Surg Pathol, 1997, 21:1466-1473. doi: 10.1097/00000478-199712000-00009 [4] Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma:the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach[J]. Am J Surg Pathol, 2007, 31:1256-1264. doi: 10.1097/PAS.0b013e3180309e6a [5] Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a highrisk group of papillary and follicular carcinomas[J]. Cancer, 1983, 52:1849-1855. doi: 10.1002/1097-0142(19831115)52:10<1849::AID-CNCR2820521015>3.0.CO;2-X [6] Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans's "wuchernde Struma"[J]. Am J Surg Pathol, 1984, 8:655-668. doi: 10.1097/00000478-198409000-00005 [7] DeLellis RA, LLoyd R, Heitz PU. WHO classification of tumors, pathology and genetics-tumors of endocrine organs[M]. Lyon, France:IARC Press, 2004. [8] Rufini V, Salvatori M, Fadda G, et al. Thyroid carcinomas with a variable insular component:prognostic significance of histopathologic patterns[J]. Cancer, 2007, 110:1209-1217. doi: 10.1002/cncr.22913 [9] Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas:how poorly differentiated is needed?[J]. Am J Surg Pathol, 2011, 35:1866-1972. doi: 10.1097/PAS.0b013e31822cf962 [10] Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid:validation of the Turin proposal and analysis of IMP3 expression[J]. Mod Pathol, 2010, 23:1269-1278. doi: 10.1038/modpathol.2010.117 [11] Papotti M, Torchio B, Grassi L, et al. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid[J]. Am J Surg Pathol, 1996, 20:686-694. doi: 10.1097/00000478-199606000-00005 [12] Volante M, Papotti M. A practical diagnostic approach to solid/trabecular nodules in the thyroid[J]. Endocr Pathol, 2008, 19:75-81. doi: 10.1007/s12022-008-9023-5 [13] Ivanova R, Soares P, Castro P, et al. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma:a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma[J]. Virchows Arch, 2002, 440:418-424. doi: 10.1007/s00428-001-0543-3 [14] Dobashi Y, Sakamoto A, Sugimura H, et. al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma[J]. Am J Surg Pathol, 1993, 17:375-381. doi: 10.1097/00000478-199304000-00008 [15] Pilotti S, Collini P, Del Bo R, et al. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland[J]. Am J Surg Pathol, 1994, 18:1054-1064. doi: 10.1097/00000478-199410000-00009